AtaiBeckley Inc. (ATAI) News
Track canonical SquawkNews coverage tagged to ATAI, AtaiBeckley Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 28 indexed stories across 14 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
As Trump backs psychedelics research, FDA weighs safety and access standards
By Nancy LapidThe U.S. FDA heard calls for clear safety and access standards for psychedelic therapies at a public meeting, the latest step in the Trump administration's push to speed development of treatments such as ib
REGULATION | Sep 15, 2026, 03:16 PM UTC
L
FDA holds public hearing on psychedelic drugs as Trump-driven push gathers pace
By Puyaan Singh and Kamal ChoudhuryThe U.S. FDA is holding a public hearing on Monday to gather feedback on the potential therapeutic use of psychedelic drugs, the latest step in a months-long push by President Donald Tr
REGULATION | Sep 14, 2026, 07:30 PM UTC
M
ATAI shareholders approve merger agreement with Eli Lilly
Shareholders approved the merger agreement with Eli Lilly and Company, and all proposals passed. Final voting results are expected within four business days.
MNA | Sep 08, 2026, 03:27 PM UTC
L
Ataibeckley-HSR waiting period for Eli Lilly merger expired Aug. 28
The Hart-Scott-Rodino waiting period for the Eli Lilly merger expired on August 28.
MNA | Aug 31, 2026, 08:44 PM UTC
M
ATAI, CRDF, GAP, LEGN, NVO Downgraded
ATAI, CRDF, GAP, LEGN, and NVO downgraded by various analysts
EQUITY | Aug 12, 2026, 10:47 AM UTC
H
Jim Cramer Calls This Industrial Stock ‘Sensational’ And Ameriprise Financial ‘Fantastic’
On CNBC’s “ Mad Money Lightning Round,” Jim Cramer said Lockheed Martin Corporation (NYSE: LMT ) is “sensational” and its CEO is “fantastic.” According to recent news, the company received a major U.S. government contrac
EARNINGS | Aug 07, 2026, 12:14 PM UTC
L
JNJ ABBV ATAI LLY J&j, AbbVie said to have also looked at AtaiBeckley before Lilly’s $2.8B deal Link To Story from ENDPOINTS.news
JNJ ABBV ATAI LLY J&j, AbbVie said to have also looked at AtaiBeckley before Lilly’s $2.8B deal Link To Story from ENDPOINTS.news
EQUITY | Jul 20, 2026, 03:24 PM UTC
L
moves among today's downgrades PENG -11.4%, FNB -2.6%, CRL -2.5%, BIRK -2.2%, FDUS -2.1%, HUBS -1.7%, ATAI -1.3%, TFC -1.2%, SCHW -0.4%, MNS
moves among today's downgrades PENG -11.4%, FNB -2.6%, CRL -2.5%, BIRK -2.2%, FDUS -2.1%, HUBS -1.7%, ATAI -1.3%, TFC -1.2%, SCHW -0.4%, MNST +0.3%, ALGM +2.9%, SNEX +3.2% moves among today's negative initiations WDAY -1
EQUITY | Jul 20, 2026, 01:43 PM UTC
L
ATAI Downgrade from Buy to Neutral W/$7.50 PT at H.C. Wainwright
ATAI Downgrade from Buy to Neutral W/$7.50 PT at H.C. Wainwright
EQUITY | Jul 20, 2026, 11:49 AM UTC
L
ATAI Downgrade from Buy to Hold at Berenberg
ATAI Downgrade from Buy to Hold at Berenberg
EQUITY | Jul 20, 2026, 11:49 AM UTC
H
Deal Dispatch: Uber Buys Delivery Hero For $14.8 Billion, Eli Lilly Acquires AtaiBeckley, Lulu’s Fashion Considers Strategic Alternatives
New On The Block Lulu’s Fashion Lounge Holdings (NASDAQ: LVLU ) retained Solomon Partners as its financial advisor and Willkie Farr & Gallagher LLP as its legal advisor as the company evaluates strategic alternatives to
EARNINGS | Jul 17, 2026, 05:18 PM UTC
L
early moves among today's downgrades NFLX -11.3%, OPCH -2.0%, SAH -1.7%, KREF -1.6%, ATAI -0.6%, AGNC -0.3%, OKE +0.1%, DSGR +0.9% early mov
early moves among today's downgrades NFLX -11.3%, OPCH -2.0%, SAH -1.7%, KREF -1.6%, ATAI -0.6%, AGNC -0.3%, OKE +0.1%, DSGR +0.9% early moves among today's negative initiations - none
EQUITY | Jul 17, 2026, 12:00 PM UTC
L
ATAI Downgrade from Buy to Hold W/$7.50 PT (from $10.00) at Jefferies
ATAI Downgrade from Buy to Hold W/$7.50 PT (from $10.00) at Jefferies
EQUITY | Jul 17, 2026, 11:56 AM UTC
H
What You Missed On Wall Street On Thursday
The major averages closed broadly lower amid a new wave of corporate earnings reports and renewed weakness in the semiconductor space. Earnings season has started off strong this week, as more than 87% of the 40 S&P 500
RATES | Jul 16, 2026, 08:25 PM UTC
H
Midday Fly By: UnitedHealth, United Airlines, GE Aersopace report Q2 beats
The Dow Jones Industrial Average was higher near noon while the S&P 500 and Nasdaq were lower as investors digest a new wave of corporate earnings reports and renewed weakness in the semiconductor space. Markets continue
MACRO | Jul 16, 2026, 04:10 PM UTC
H
Abbott Laboratories, AtaiBeckley, ManpowerGroup And Other Big Stocks Moving Higher On Thursday
U.S. stocks were mixed, with the Nasdaq Composite falling around 150 points on Thursday. Shares of Abbott Laboratories (NYSE: ABT ) rose sharply after the company reported better-than-expected second-quarter financial re
EARNINGS | Jul 16, 2026, 02:11 PM UTC
L
CMPS also +9% premarket after ATAI M&A headlines
CMPS also +9% premarket after ATAI M&A headlines
MNA | Jul 16, 2026, 11:28 AM UTC
L
Peer GHRS +14% premarket after ATAI M&A headlines
Peer GHRS +14% premarket after ATAI M&A headlines
MNA | Jul 16, 2026, 11:15 AM UTC
H
Lilly To Acquire AtaiBeckley For $6.75 Per Share In Cash Plus Up To $2.50 Per Share In A Contingent Value Right Dependent Upon Milestones Re
Eli Lilly and Company (NYSE: LLY ) and AtaiBeckley Inc. (NASDAQ: ATAI ), a clinical-stage biopharmaceutical company developing innovative therapeutics for mental health conditions, today announced a definitive agreement
EARNINGS | Jul 16, 2026, 10:49 AM UTC
L
LLY ATAI Eli Lilly - boards of both companies approve deal Eli Lilly: will determine accounting treatment of this transaction in accordance
LLY ATAI Eli Lilly - boards of both companies approve deal Eli Lilly: will determine accounting treatment of this transaction in accordance with GAAP upon closing
EQUITY | Jul 16, 2026, 10:46 AM UTC
L
ATAI LLY(confirmed) lilly to acquire ataibeckley to advance Therapies for treatment-resistant depression and other mental health conditions
ATAI LLY(confirmed) lilly to acquire ataibeckley to advance Therapies for treatment-resistant depression and other mental health conditions Eli Lilly - to pay $6.75 per share cash plus up to $2.5 per share in cvr - Deal
MNA | Jul 16, 2026, 10:45 AM UTC
H
FDA announces availability of final guidance for psychedelic drug research
The agency said,...
EARNINGS | Jul 15, 2026, 03:12 PM UTC
H
Jefferies says guidance suggests FDA receptive to helping psychedelic sponsors
Jefferies notes that on...
EQUITY | Jul 13, 2026, 05:12 PM UTC
L
Psychedelic: Compass Pathways reports six-month data for psilocybin drug
In this week's "Psychedelic," recurring series focused on psychedelic stock news, looks back on study results, drug delivery evaluation and last patient dosing. COMPASS PATHWAYS REPORTS SIX-MONTH DATA FROM COMP006 TRIAL:
EQUITY | Jul 09, 2026, 01:49 PM UTC
L
AtaiBeckley rumor highlighted in Betaville blog
The Betaville M&A blog has highlighted a rumor regarding AtaiBeckley, contacts tell.
MNA | Jul 06, 2026, 01:50 PM UTC
L
AtaiBeckley Completes Patient Dosing In Depression Drug Trial, Expects Depression Treatment Trial Data In Late 2026
AtaiBeckley Inc. (NASDAQ: ATAI ) ("AtaiBeckley" or "Company"), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient mental health treatments
EQUITY | Jul 06, 2026, 10:03 AM UTC
L
AtaiBeckley Doses Last Patient in VLS-01 Phase 2b TRD Study; Plans Phase 3 in Major Depressive Disorder
156 patients randomized in multi-center, double-blind, placebo
EQUITY | Jul 06, 2026, 10:00 AM UTC
L
ATAI Joins Russell Indexes
Atai Life Sciences' subsidiary AtaiBeckley to join the Russell Indexes, expanding visibility across U.S. equity markets
EQUITY | Jun 25, 2026, 10:00 AM UTC